Navigation Links
Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced
Date:12/4/2009

TARRYTOWN, N.Y., Dec. 4 /PRNewswire/ -- Bayer Diabetes Care today announced the three grand prize winners of Bayer's "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winning video entries submitted by children with diabetes from across the country. The grand prize is an in-person meeting today with Nick.

The winners, who have type 1 diabetes like Nick, are: Caleb, age 6, from Danbury, CT, who dreams of becoming a major league pitcher one day. Caleb's Simple Win is being able to play baseball. Bradley, age 11, from Monaca, PA, whose Simple Win is music, loves to sing and has even written some of his own songs. Lauren, age 16, from Gurnee, IL, who volunteers with local organizations and her Simple Win is giving back to her community.

To enter the contest, young people with diabetes were asked to create a 15-30 second video creatively showing how they express their Simple Win, whether through an original lyric, drawing, photo, or other idea.

Bayer Diabetes Care and Nick Jonas established the "Express Your Simple Win Creativity Contest" as part of their ongoing partnership to educate and motivate people living with diabetes. Nick, who uses Bayer's CONTOUR® meter, has inspired young people with diabetes by sharing his Simple Wins: writing lyrics, performing and making music. He was able to creatively express himself through his song about living with diabetes, "A Little Bit Longer."

"I'm inspired by fans who share their stories about living with diabetes, so for me this has been a great experience," said Nick. "I want kids to know that diabetes doesn't have to hold you back. Caleb, Bradley, Lauren, and all the other participants who submitted videos, are great examples of kids achieving their Simple Wins. My hope is that by sharing our stories, we can motivate others to achieve and celebrate their own Simple Wins."

Through their partnership, Nick and Bayer have taken steps to inspire young people with diabetes to achieve Simple Wins: small, everyday victories for managing diabetes that can lead to big differences over time.

Winner Lauren said, "I love helping others who need help because I know what it's like to feel overwhelmed by living with diabetes. Having a support system makes the struggle easier, so I hope I can be someone else's support system and help them get through a rough time. I know I will never be able to touch the number of lives that Nick can, but that is why I reach out as much as I can to those in need."

Over the past several months, more than 160 kids with diabetes uploaded their videos on www.NicksSimpleWins.com and during the last week of each month visitors to the site had the opportunity to view and vote for their favorite three videos. Each monthly winner received a prize and was eligible for the grand prize drawing.

To see the winning contest entries, learn more about the ongoing partnership between Bayer and Nick Jonas or read about Nick's personal experience with diabetes, visit www.NicksSimpleWins.com.

Bayer Diabetes Care

Bayer Diabetes Care is a worldwide leader in diabetes, supporting customers in 100 countries and, for more than 40 years, has led the way in diabetes care product innovation. Bayer introduced the first portable blood glucose meter and test strips, innovated the measurement of A1C (glycated hemoglobin) with A1CNow+® and A1CNow® SELFCHECK and was the first to offer a suite of blood glucose monitors (CONTOUR® and BREEZE®2) with No Coding(TM) technology. Additionally, Bayer's meters feature no interference from maltose and galactose, making diabetes management easier. Today, Bayer Diabetes Care offers an unparalleled choice in diabetes management systems and comprehensive support including education, tools and resources designed to simplify life with diabetes.

Bayer Diabetes Care is a business of the Bayer HealthCare LLC, Medical Care Division and has its global headquarters located in Tarrytown, New York. For more information, visit www.bayerdiabetes.com or in the U.S. www.simplewins.com.

Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

SOURCE Bayer Diabetes Care


'/>"/>
SOURCE Bayer Diabetes Care
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):